Connect with us

Hi, what are you looking for?


Exxon stock price forecast: UBS sees 25% upside from here

Shares of Exxon Mobil Corp (NYSE: XOM) have gained nearly 17% over the past month but a UBS analyst says the upside will continue to unravel moving forward.

Exxon stock should be worth $144

Josh Silverstein upgraded the oil and gas behemoth this morning to “buy” and raised his price objective to $144 – a near 25% upside from here.

The analyst expects Exxon stock to outperform its peers in the midst of elevated oil prices. His research note reads:

We see the Integrated Oils as best positioned to outperform this upcycle, driven by improved balance sheets and significantly more capital efficient asset bases that generate higher free cash flow.

The energy company is scheduled to report its Q1 results later this month. Consensus is for it to earn $2.63 a share versus $2.07 per share a year ago.

Why else should you buy Exxon stock?

Silverstein is convinced that Exxon will have net cash on its balance sheet by mid-2024 that’ll help lift the rate at which it buys back stock above $17.5 billion a year. Last week, the oil giant was said to be in preliminary talks to buy Pioneer Natural Resources as Invezz reported HERE.

Continued growth in Irving-headquartered company’s upstream and downstream businesses was among other reasons cited for the constructive view.

Our positive outlook is driven by high margin upstream volume growth 2%/3% above 2024/25 consensus that are paired with annual downstream/chemicals capacity additions, while maintaining capex at $20-$25 Bn/yr.

The multinational currently pays a dividend yield of 3.13% that may also be exciting for those interested in buying Exxon stock today.

The post Exxon stock price forecast: UBS sees 25% upside from here appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.